Shire's oncology exit weighs on potential Takeda bid

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 17, 2018 at 9:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    6,851
    Likes Received:
    1
    via Shire plc is backing out of cancer drugs, announcing Monday the sale of its oncology business to French pharma Servier S.A.S. for $2.4 billion in cash.

    article source